During the last session, Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares were 0.99 million, with the beta value of the company hitting 1.88. At the end of the trading day, the stock’s price was $0.34, reflecting an intraday gain of 11.51% or $0.03. The 52-week high for the PTPI share is $2.27, that puts it down -567.65 from that peak though still a striking 35.29% gain since the share price plummeted to a 52-week low of $0.22. The company’s market capitalization is $3.46M, and the average intraday trading volume over the past 10 days was 2.05 million shares, and the average trade volume was 2.01 million shares over the past three months.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Petros Pharmaceuticals Inc (PTPI) registered a 11.51% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 11.51% in intraday trading to $0.34, hitting a weekly high. The stock’s 5-day price performance is 15.00%, and it has moved by 10.54% in 30 days. Based on these gigs, the overall price performance for the year is -73.26%. The short interest in Petros Pharmaceuticals Inc (NASDAQ:PTPI) is 0.2 million shares and it means that shorts have 0.72 day(s) to cover.

PTPI Dividends

Petros Pharmaceuticals Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Petros Pharmaceuticals Inc insiders own 8.10% of total outstanding shares while institutional holders control 2.29%, with the float percentage being 2.49%.